Don’t Miss TipRanks’ Half Year Sale
- Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Q-linea AB ( (SE:QLINEA) ) has shared an update.
Q-linea AB has announced its annual general meeting scheduled for June 26, 2025, in Uppsala, Sweden. Key agenda items include the election of board members, approval of financial statements, and decisions on share capital adjustments. The nomination committee proposes no dividend for 2024, a slight increase in board remuneration, and resolutions on share capital reduction and extension of a loan from a related party. These decisions are aimed at strengthening the company’s financial position and governance structure.
More about Q-linea AB
Q-linea AB is a company operating in the biotechnology industry, primarily focused on developing and providing innovative diagnostic solutions. The company’s market focus includes rapid and accurate diagnostic testing, which is crucial for effective patient care and management.
Average Trading Volume: 38,921,716
Current Market Cap: SEK214.4M
See more insights into QLINEA stock on TipRanks’ Stock Analysis page.